AIM: (-)-epicatechin gallate (ECg) modifies the morphology, cell wall architecture and beta-lactam antibiotic susceptibility of Staphylococcus aureus. As these effects result primarily from intercalation into the bacterial cytoplasmic membrane, the capacity of ECg to modulate the secretion of two key staphylococcal virulence factors, coagulase and alpha-toxin, was examined. METHODS AND RESULTS: Bioassays were used to determine coagulase and haemolysin activity in culture supernatants of a number of S. aureus isolates grown in the presence and absence of ECg; alpha-toxin secretion was also evaluated by immunoblotting. Growth in ECg reduced the levels of activity of both proteins in culture supernatants; the effects could only be partly explained by ECg-mediated inhibition of bioactivity and by induction of secreted proteases. CONCLUSION: ECg suppresses the secretion of coagulase and alpha-toxin by clinical isolates of S. aureus. SIGNIFICANCE AND IMPACT OF THE STUDY: The observation that secretion of key components of staphylococcal virulence can be compromised by a naturally occurring polyphenol supports the notion that ECg and related compounds may have therapeutic utility for the control of infections that are currently difficult to treat due to the propensity of methicillin-resistant S. aureus to accumulate antibiotic resistance genes.
AIM: (-)-epicatechin gallate (ECg) modifies the morphology, cell wall architecture and beta-lactam antibiotic susceptibility of Staphylococcus aureus. As these effects result primarily from intercalation into the bacterial cytoplasmic membrane, the capacity of ECg to modulate the secretion of two key staphylococcal virulence factors, coagulase and alpha-toxin, was examined. METHODS AND RESULTS: Bioassays were used to determine coagulase and haemolysin activity in culture supernatants of a number of S. aureus isolates grown in the presence and absence of ECg; alpha-toxin secretion was also evaluated by immunoblotting. Growth in ECg reduced the levels of activity of both proteins in culture supernatants; the effects could only be partly explained by ECg-mediated inhibition of bioactivity and by induction of secreted proteases. CONCLUSION:ECg suppresses the secretion of coagulase and alpha-toxin by clinical isolates of S. aureus. SIGNIFICANCE AND IMPACT OF THE STUDY: The observation that secretion of key components of staphylococcal virulence can be compromised by a naturally occurring polyphenol supports the notion that ECg and related compounds may have therapeutic utility for the control of infections that are currently difficult to treat due to the propensity of methicillin-resistant S. aureus to accumulate antibiotic resistance genes.
Authors: H-H Sherry Chow; Yan Cai; Iman A Hakim; James A Crowell; Farah Shahi; Chris A Brooks; Robert T Dorr; Yukihiko Hara; David S Alberts Journal: Clin Cancer Res Date: 2003-08-15 Impact factor: 12.531
Authors: Paul D Stapleton; Saroj Shah; Kerstin Ehlert; Yukihiko Hara; Peter W Taylor Journal: Microbiology (Reading) Date: 2007-07 Impact factor: 2.777
Authors: Paul D Stapleton; Saroj Shah; James C Anderson; Yukihiko Hara; Jeremy M T Hamilton-Miller; Peter W Taylor Journal: Int J Antimicrob Agents Date: 2004-05 Impact factor: 5.283
Authors: En Hyung Chang; Peter Giaquinto; Joanne Huang; Nataliya V Balashova; Angela C Brown Journal: Mol Oral Microbiol Date: 2019-12-26 Impact factor: 3.563
Authors: Patricia Bernal; Sandrine Lemaire; Mariana G Pinho; Shahriar Mobashery; Jason Hinds; Peter W Taylor Journal: J Biol Chem Date: 2010-06-01 Impact factor: 5.157
Authors: Luana de Jesus Reis Rosa; Gleidy Ana Araujo Silva; Jorge Amaral Filho; Magali Glauzer Silva; José Carlos Cogo; Francisco Carlos Groppo; Yoko Oshima-Franco Journal: J Venom Res Date: 2010-09-30